OPNT - Opiant Pharmaceuticals Inc. (OPNT) CEO Roger Crystal on Q3 2019 Results - Earnings Call Transcript
Opiant Pharmaceuticals, Inc. (OPNT)
Q3 2019 Earnings Conference Call
November 12, 2019, 04:30 PM ET
Company Participants
Rahsaan Thompson - General Counsel
Roger Crystal - CEO
David O'Toole - CFO
Conference Call Participants
David Bautz - Zacks
Presentation
Operator
Greetings, and welcome to the Opiant Pharmaceuticals Third Quarter 2019 Earnings Conference Call. At this all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Rahsaan Thompson, General Counsel